Evidence map›Paper›PMID 25977939›Full record

ArticleMolecular & cellular oncology

The next new target in leukemia: The embryonic stem cell gene

Fei Wang, Wenxiu Zhao, Nikki Kong, Wei Cui, Li Chai

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular & cellular oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. The Impact of Iron Chelators on the Biology of Cancer Stem Cells.International journal of molecular sciences · 2021
    Review
  7. Article
  8. Role of Stem-Cell Transplantation in Leukemia Treatment.Stem cells and cloning : advances and applications · 2020
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Stemness-Related Markers in Cancer.Cancer translational medicine · 2017
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 3 countries.

Fei WangDepartment of Pathology Brigham and Women's Hospital; Harvard Medical School; Boston, MA USA ; Department of Clinical Laboratory; Peking Union Medical College Hospital; Peking Union Medical College and Chinese Academy of Medical Sciences; Beijing, China.
Wenxiu ZhaoDepartment of Pathology Brigham and Women's Hospital; Harvard Medical School; Boston, MA USA.
Nikki KongDepartment of Pathology Brigham and Women's Hospital; Harvard Medical School; Boston, MA USA.
Wei CuiDepartment of Clinical Laboratory; Peking Union Medical College Hospital; Peking Union Medical College and Chinese Academy of Medical Sciences; Beijing, China.
Li ChaiDepartment of Pathology Brigham and Women's Hospital; Harvard Medical School; Boston, MA USA.
Harvard University · USChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

Transcription regulation in hematopoiesisP01HL095489 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI PARK, SHINYOUNG · 2010 to 2020
$20.1M
TRANSFUSION BIOLOGY AND MEDICINET32HL066987 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI JOHN P MANIS · 2001 to 2026
$10.2M
SELF-RENEWAL IN LEUKEMIC STEM CELLSR01HL092437 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI CHAI, LI · 2008 to 2012
$2.4M
NHLBI NIH HHS P01 HL095489NHLBI NIH HHS R01 HL092437NHLBI NIH HHS T32 HL066987
6 · The paper itself

Abstract

The embryonic stem (ES) cell gene

Indexed as

AMLES cell geneHOXA9MDSSALL4

Identifiers

PMID25977939
PMCPMC4428154
OpenAlexW1972789483

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.